Selective reporting biases in cancer prognostic factor studies

被引:184
作者
Kyzas, PA
Loizou, KT
Ioannidis, JPA [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece
[2] Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina, Greece
[3] Tufts Univ, New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Dept Med, Boston, MA 02111 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2005年 / 97卷 / 14期
关键词
D O I
10.1093/jnci/dji184
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Nonreported and selectively reported information and the use of different definitions may introduce biases in the literature of prognostic factors. We probed these biases in a meta-analysis of a prognostic factor for head and neck squamous cell cancer (HNSCC) mortality that has drawn wide attention-the status of the tumor suppressor protein TP53. Methods: We compared results of meta-analyses that included published data plus unpublished data retrieved from investigators; published data; and only published data indexed with "survival" or "mortality" in MEDLINE/EMBASE, with or without standardized definitions. We also evaluated whether previously published meta-analyses on mortality predictors for various malignancies addressed issues of retrieval and standardized information. All statistical tests were two-sided. Results: For the 18 studies with 1364 patients that included published and indexed data, we obtained a highly statistically significant association between TP53 status and mortality. When we used the definitions preferred by each publication, the association was stronger (risk ratio [RR] = 1.38, 95% confidence interval [CI] = 1.13 to 1.67; P =.001) than when we standardized definitions (RR = 1.27, 95% CI = 1.06 to 1.53; P =.011). The addition of 13 studies with 1028 subjects that included published but not indexed data reduced the observed association (RR = 1.23, 95% CI = 1.03 to 1.47; P =.02). Finally, when we obtained data from investigators (11 studies with 996 patients) and analyzed it with all other data, statistical significance was lost (RR = 1.16, 95% CI = 0.99 to 1.35; P =.06). Among 18 published meta-analyses of 37 cancer prognostic factors, 13 (72%) did not use standardized definitions and 16 (89%) did not retrieve additional information. Conclusions: Selective reporting may spuriously inflate the importance of postulated prognostic factors for various malignancies. We recommend that meta-analyses thereof should maximize retrieval of information and standardize definitions.
引用
收藏
页码:1043 / 1055
页数:13
相关论文
共 135 条
[1]  
AHOMADEGBE JC, 1995, ONCOGENE, V10, P1217
[2]   TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck [J].
Alsner, J ;
Sorensen, SB ;
Overgaard, J .
RADIOTHERAPY AND ONCOLOGY, 2001, 59 (02) :179-185
[3]   DANGERS OF USING OPTIMAL CUTPOINTS IN THE EVALUATION OF PROGNOSTIC FACTORS [J].
ALTMAN, DG ;
LAUSEN, B ;
SAUERBREI, W ;
SCHUMACHER, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (11) :829-835
[4]   Methodological challenges in the evaluation of prognostic factors in breast cancer [J].
Altman, DG ;
Lyman, GH .
BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) :289-303
[5]   Systematic reviews in health care - Systematic reviews of evaluations of prognostic variables [J].
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7306) :224-228
[6]   P53 overexpression in head and neck carcinoma and radiotherapy results [J].
Awwad, S ;
Jaros, E ;
Somes, J ;
Lunec, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (02) :323-332
[7]   OPERATING CHARACTERISTICS OF A BANK CORRELATION TEST FOR PUBLICATION BIAS [J].
BEGG, CB ;
MAZUMDAR, M .
BIOMETRICS, 1994, 50 (04) :1088-1101
[8]   Clinical epidemiological quality in molecular genetic research - The need for methodological standards [J].
Bogardus, ST ;
Concato, J ;
Feinstein, AR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (20) :1919-1926
[9]   OVEREXPRESSION OF P53 PREDICTS ORGAN PRESERVATION USING INDUCTION CHEMOTHERAPY AND RADIATION IN PATIENTS WITH ADVANCED LARYNGEAL-CANCER [J].
BRADFORD, CR ;
ZHU, SB ;
WOLF, GT ;
POORE, J ;
FISHER, SG ;
BEALS, T ;
MCCLATCHEY, KD ;
CAREY, TE ;
HONG, WK ;
URBA, S ;
ENDICOTT, JW ;
CLOSE, L ;
FISHER, SR ;
TOOHILL, RJ ;
KARP, D ;
MILLER, DM ;
CHEUNG, NK ;
WEAVER, A ;
HILLEL, AD ;
SPAULDING, M ;
CHANG, BK ;
DOUGHERTY, B ;
DECONTI, R ;
GAREWAL, H ;
FYE, C .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1995, 113 (04) :408-412
[10]   p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma:: A prospective series [J].
Cabelguenne, A ;
Blons, H ;
de Waziers, I ;
Carnot, F ;
Houllier, AM ;
Soussi, T ;
Brasnu, D ;
Beaune, P ;
Luccourreye, O ;
Laurent-Puig, P .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) :1465-1473